Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a, Randomized, Double-blind, Placebo-controlled Trial of PRV-3279 EVAluation In Lupus

NCT05087628 is registered in ClinicalTrials.gov with Provention Bio, a Sanofi Company as lead sponsor.

NCT NCT05087628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05087628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a, Randomized, Double-blind, Placebo-controlled Trial of PRV-3279 EVAluation In Lupus
Lead sponsor
Provention Bio, a Sanofi Company
Phase
Phase 2
Overall status
Terminated
Start date
January 20, 2022
Completion date
June 24, 2024
Enrollment
28 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus